Wesley Hospital Kogarah
Sydney, New South Wales, 2217, Australia
NCT Number: NCT03105245
This study will examine how anaesthetic technique affects ECT outcomes. Specifically, the investigators will examine how: 1) the time interval between anaesthetic and ECT stimulus, and 2) the ventilation rate before ECT stimulus, impacts on the quality of the EEG (this is a recording of brain activity during ECT and is used to judge the quality of a seizure and to guide individual patient dosing).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Sydney, New South Wales, 2217, Australia
This study aims to examine how the time interval between administration of anaesthetic agent and ECT stimulus delivery impacts upon measures of EEG quality (seizure quality).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention in this study is the time interval between anaesthetic administration and ECT stimulus
Time frame: Outcome measures will be collected immediately after each ECT treatment from the first treatment until the end of the ECT course, an estimated total of four to six weeks for most participants
EEG quality will be rated manually for each ECT treatment undertaken by a participant until the conclusion of their ECT course. This rating will be done using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al - low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy; Journal of Affective Disorders, 2010; 126: 330-333
The University of New South Wales
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05254379
Behavior, Behavioral Symptoms
Atlanta, Georgia, United States
View Trial DetailsNCT07771413
Behavior, Behavioral Symptoms
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04886856
Behavior, Behavioral Symptoms
Richmond, Virginia, United States
View Trial DetailsNCT06481033
Behavior, Behavioral Symptoms
The Bronx, New York, United States
View Trial Details